We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
The ASX200 has been down 0.34% at 8,345 points, as the bourse pulls back from yesterday’s record hig...
Read ArticlePainchek is eyeing a market of 1.7 million US aged-care beds for its pain-detection device Genetic...
Read ArticlePainChek (ASX:PCK) has applied for Food and Drug Administration (FDA) De Novo approval for its new P...
Read ArticlePhilip Daffas – CEO & Managing Director – PainChek Limited (ASX:PCK) is a digital health compa...
Read ArticleASX rises following Wall Street’s lead Cettire drops 12pc after disappointing earnings update Ret...
Read ArticlePainChek (ASX: PCK) has announced positive outcomes from a US clinical validation study that will al...
Read ArticleGood morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highligh...
Read ArticleArgent Biopharma packs its bags for London on a one-way ticket Patrys shares slump 50% on cancellat...
Read ArticlePainChek (ASX:PCK) has updated the market on the progress of its De Novo submission to the US FDA fo...
Read ArticlePainChek granted patent in Europe PainChek (ASX:PCK) has been granted a patent in 20 European nation...
Read ArticlePeter Milios: I'm Peter Milios from the Finance Use Network, and today I'm talking with PainChek....
Read ArticleTo register for Friday's webinar click here. PainChek (ASX:PCK), developer of the world’s first sm...
Read Article14 Mar 2024 - A snapshot of the stocks on the move, featuring PainChek (ASX:PCK), Chimeric Therapeut...
Read ArticleAfter a day of profit taking yesterday, the ASX200 is set to stablilise, with futures tipping a 0.2...
Read ArticlePhilip Daffas, CEO & Managing Director, PainChek (ASX:PCK) develops mobile medical application...
Read ArticleASX200 dragged down by bad drugs The IT Sector is up 1.1pc, Healthcare is down about 3.2pc Small...
Read ArticleASX medical devices to make inroads with FDA after a good year for drug developers FDA is reviewing...
Read ArticlePainChek’s European patent HeraMed signs deal with Telstra AdAlta announced interim Phase 1 results...
Read ArticlePhilip Daffas – CEO & Managing Director – PainChek (ASX:PCK) develops mobile medical applicati...
Read ArticleStockhead’s Top 10 at shortly-before-11-ish, fuelled by caffeine and rage, because it’s Friday and t...
Read ArticleBenchmark index finishes higher on strong oil prices ASX Sectors led by oil-driven gains for Energ...
Read ArticleL’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supr...
Read ArticleWhat stocks trading at 52-week highs are telling us How do we know if they are overbought or overso...
Read ArticleWelcome to Market Close From The Floor at the Critical Minerals and Energy Investment Conference in...
Read ArticleBenchmark slides throughout the day after a shocker on Wall Street last night. Utilities did best b...
Read ArticleASX biotech stock PainChek Ltd (ASX: PCK) rocketed 36% higher this afternoon, prompting the ASX to...
Read ArticlePainChek (PCK) secures firm commitments to raise $3.55 million through a share placement The comp...
Read ArticleThe $36 million ASX-listed company had Canaccord Genuity rounding up investors at 2.7¢ a pop.
Read ArticleASX200 ends choppy day 0.2% higher Miners and med stocks offset banks and Energy Small caps led b...
Read ArticleThe Federal Budget delivers billions of dollars funding into healthcare and aged care Mental health...
Read ArticleJapanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based devic...
Read ArticlePainChek (PCK) is expanding into Japan after being accepted into the JETRO Business Connect program...
Read ArticleBotanix submits NDA to the US FDA Pharmaxis reports on latest clinical trials PainChek to expand to...
Read ArticlePainChek (PCK) receives funding for a 12-month pilot program in care environments across Wales The...
Read ArticleShareCafeWebinar Recap – PCK, OCC, LCL & ICE Catch up on the full webinar presentations from Pa...
Read ArticleShareCafePainCheck (ASX: PCK) – Webinar presentation Philip Daffas – CEO & MD – PainChek is tra...
Read ArticleA recent research reveals which biotech segments VCs are ploughing billions of dollars into We list...
Read ArticlePainChek (PCK) receives a $392,820 grant from the Western Australia State Government’s Future Healt...
Read ArticlePainChek (PCK) hopes to raise $4.59 million through an entitlement offer and share placement to acc...
Read ArticleAvita Medical makes spray on skin for burns and soft tissue injuries HITIQ’s concussion tech is pop...
Read ArticleTech leads losses on local markets ASX 200 gives away early gains, XEC dives more than 1% again BN...
Read ArticlePainChek (PCK) enters a mid-week trading halt regarding the release of a placement and non-renounce...
Read ArticleIt’s still dead quiet in equity capital markets, but two microcaps were out testing the waters after...
Read ArticleBiotech sector has had a tough time recently But there are signs of things improving this year A lo...
Read ArticleThe healthcare sector is Australia’s biggest employer, employing 1 in 7 Aussies or roughly two milli...
Read ArticlePainChek (PCK) is rolling out its pain assessment solution through retirement village and aged care...
Read ArticleOncosil’s medical device will be used in a German government funded clinical trial PainChek to expa...
Read ArticleASX to rise to start Budget week The Treasury will deliver its 2022/23 Federal Budget at 7pm on Tues...
Read ArticleAn additional news report on the recommendation, valuation, forecast and opinion changes for ASX-lis...
Read ArticlePainChek Ltd (ASX: PCK) has been dealt a speeding ticket today following its share price and tradin...
Read ArticleSYDNEY, Oct. 16, 2021 /PRNewswire/ — Ensuring healthy lives and promoting physical and mental wel...
Read ArticleS&P 500 closed at record high again Wall Street closed Friday mostly on a high note, with the S&...
Read ArticleA big surge in energy shares led the ASX into positive territory for the second day in a row. The AS...
Read ArticleSummary Day after scaling a record high level, the ASX 200 on Thursday again opened higher. The...
Read ArticleThere are 50 million people living with dementia and 400 million pre-verbal children, at any given p...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleShares in PainChek Ltd (ASX: PCK) are gaining today after news the company has received regulatory...
Read ArticleSummary Advanced Human Imaging has entered into a binding agreement with Jana Care to bring affo...
Read ArticleIt was a good morning for shareholders of PainChek (ASX:PCK) and Advanced Human Imaging (ASX:AHI), a...
Read ArticleWall Street slips for third consecutive day Inflation worries have persisted in the market, with all...
Read ArticleThere were only nice surprises in the aged-care funding announced by the Treasurer last night, with...
Read ArticleSummary With the current emergency, it is anticipated that telehealth or telemedicine could be t...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks f...
Read ArticleThe PainChek Ltd (ASX: PCK) share price is soaring today after the company announced it has receive...
Read ArticleSource:MonsterStudio,Shutterstock Summary Mobile-based healthcare technology developer PainChek...
Read ArticlePainChek (ASX:PCK) says it has received regulatory approval to market the next generation of its pai...
Read ArticleWall Street pulls back Blue chip Dow Jones finally had an off-day, falling by 0.39% after reaching c...
Read ArticlePeter Switzer is joined by Philip Daffas, the CEO and Managing Director of Painchek (PCK).
Read ArticleShareCafeHidden Gems Webinar Recap – PCK, CV1, GLN, CE1 – 26/2/21 Catch up on the full webinar with...
Read ArticleShareCafePainChek (ASX:PCK) – Hidden Gems Webinar Presentation Presenter – Philip Daffas – CEO &...
Read ArticleThe PainChek Ltd (ASX: PCK) share price was among the few ASX shares that stayed in the green today...
Read ArticleNext week marks one year since the S&P/ASX All Technology Index (ASX: XTX) debuted. Launched at...
Read ArticleThe Painchek Ltd (ASX: PCK) share price climbed today after the company provided the market with a...
Read ArticleSummary PainChek® has completed PainChek Infant Face-Only clinical trial to support regulatory c...
Read ArticleIt’s been another positive day on the ASX in the wake of Democrats gaining control of the US Senate...
Read ArticleThe PainChek Ltd (ASX: PCK) share price is dropping lower on Friday morning following the release o...
Read ArticleStockhead’s resident Health and Biotech expert Tim Boreham is putting down the pen and picking up th...
Read ArticleThe ASX200 rose 2.2% in August with technology and consumer discretionary leading the way during the...
Read ArticleShareCafePainChek – ShareCafe Hidden Gems Webinar Presentation Presenter – Philip Daffas – CEO &a...
Read ArticleShareCafeHidden Gems Webinar Recap – PCK, WOA, PYG, AJQ We continue to unearth small-cap companie...
Read ArticleMobile medical device outfit PainChek was out hunting for fresh capital on Friday to finance taking...
Read ArticleTelehealth use has only continued to increase as COVID-19 wore on throughout May and June. Both list...
Read ArticleThe journey of each individual medical treatment from idea to market requires the involvement of mul...
Read ArticleAlmost all of the ASX’s health small caps have visions as ambitious as the Australian and state gove...
Read ArticleLast year was a solid year for many ASX stocks and 2020 was also looking pretty good until COVID-19...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. Of the ASX’s 137-odd small ca...
Read Article08 May 2020 - PainChek® (ASX:PCK) has received a notice of allowance from the Australian Patent Offi...
Read ArticleToday Stockhead has gone through the best and worst 4C releases so you don’t have to. And tech compa...
Read ArticleAustralian medical device company PainChek (ASX: PCK) has reported a strong performance for the Marc...
Read ArticleMobile medical app developer Painchek Ltd [ASX:PCK] has seen its share price jump 13.24% today, up 0...
Read ArticleMedical device company PainChek (ASX: PCK) confirmed it has met an important 25,000 licenced bed mil...
Read ArticleDementia already affects hundreds of thousands of people in Australia, and it’s only going to get wo...
Read ArticleAn additional news report on the recommendation, valuation, forecast and opinion changes for ASX-lis...
Read ArticleAustralian company PainChek (ASX:PCK) says it been granted a patent in Japan for its smartph...
Read ArticleThe European Commission has granted Orphan drug status for Alterity Therapeutics’ (ASX:ATH) lead mol...
Read ArticleIt’s fair to assume PainChek (ASX:PCK) shareholders are a happy bunch with a 12-month share price ri...
Read ArticleAs the year winds down and AGM season concludes brokers have been busy filling their Christmas stock...
Read ArticleAustralian medical device company PainChek (ASX: PCK) is expanding its presence in the UK market, ma...
Read ArticlePainChek Limited (ASX: PCK) has received first 1,000 PainChek annual bed license order from Person C...
Read ArticleShort & Caught is Stockhead’s fortnightly recap of which ASX small cap stocks are heavily shorte...
Read ArticleWe hate to sound like an old school report, but it’s been a year of steady and solid progress for th...
Read ArticleAs the saying goes, if you can make it in New York you can make it anywhere. But for the home-grown...
Read ArticleIn a submission to the aged care royal commission, Queen of Pain Prof Jennifer Abbey presented a har...
Read ArticleThe TechKnow Invest Roadshow provides retail and institutional investors, as well as brokers, an opp...
Read ArticlePainChek (ASX: PCK) has announced that it intends to partner up with Ward Medication Management (War...
Read ArticleThis year has been a positive one for ASX small caps. According to Bloomberg, the average small cap...
Read ArticleAbout Penny Stocks Stocks that trade at a significantly lower price with low market capitalisation a...
Read ArticleResources companies have come out on top in ASX small caps over the past 12 months – but now only ac...
Read ArticleA lot of retail share market traders like to pile into whatever’s hot or going up fast in the small...
Read ArticleDiversification Diversification can be done by investing in different types of securities. This stra...
Read Article05 Sep 2019 - PainChek (ASX:PCK) has appointed Pete Shergill as the Head of Business Development for...
Read ArticleIn today’s contemporary world, technology has a major impact on businesses. This simple fact gets in...
Read ArticleTechnology is the use of scientific knowledge for practical purposes, and it forms an important aspe...
Read ArticleAustralian medical device company PainChek (ASX: PCK) has advanced its international expansion strat...
Read ArticleMedibio (ASX: MEB) has gained 24 per cent this morning after announcing an integration partnership w...
Read ArticleThe Clean TeQ Holdings Limited (ASX: CLQ) share price is defying the broader market weakness as it...
Read ArticleThe CSIRO’s ON accelerator program, in partnership with the Menzies Foundation, has launched a $90,0...
Read ArticleOn 3 July 2019, the headline index S&P/ASX 200 index was up by 0.55%. Also, S&P/ASX 200 Info...
Read ArticleAs part of its plan to expand its PainChek app to children worldwide, PainChek (ASX: PCK) has teamed...
Read ArticleThis week I took a look at the 10 best-performing large cap and mid cap shares so far in 2019. Out...
Read ArticleToday, we’ll look at why the PainChek share price [ASX:PCK] initially went down and the details of i...
Read ArticleToday, we look at some possible outcomes from the Painchek (ASX:PCK) trading halt. The Painchek shar...
Read ArticlePenny stocks are those common stocks whose share price is less than $1. In other words, Penny stocks...
Read ArticleIf you are looking for examples of companies that reflect the strange market valuations that are aro...
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
